NASDAQ
Lotus Pharmaceuticals, Inc. (LTUS) has a revenue compound annual growth rate of 31.70% over 5 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.